Advertisement
Research Article Free access | 10.1172/JCI116897
Dipartimento di Medicina ed Oncologia Sperimentale, Università di Torino, Italy.
Find articles by Costelli, P. in: JCI | PubMed | Google Scholar
Dipartimento di Medicina ed Oncologia Sperimentale, Università di Torino, Italy.
Find articles by Carbó, N. in: JCI | PubMed | Google Scholar
Dipartimento di Medicina ed Oncologia Sperimentale, Università di Torino, Italy.
Find articles by Tessitore, L. in: JCI | PubMed | Google Scholar
Dipartimento di Medicina ed Oncologia Sperimentale, Università di Torino, Italy.
Find articles by Bagby, G. in: JCI | PubMed | Google Scholar
Dipartimento di Medicina ed Oncologia Sperimentale, Università di Torino, Italy.
Find articles by Lopez-Soriano, F. in: JCI | PubMed | Google Scholar
Dipartimento di Medicina ed Oncologia Sperimentale, Università di Torino, Italy.
Find articles by Argilés, J. in: JCI | PubMed | Google Scholar
Dipartimento di Medicina ed Oncologia Sperimentale, Università di Torino, Italy.
Find articles by Baccino, F. in: JCI | PubMed | Google Scholar
Published December 1, 1993 - More info
Rats bearing the Yoshida AH-130 ascites hepatoma showed enhanced fractional rates of protein degradation in gastrocnemius muscle, heart, and liver, while fractional synthesis rates were similar to those in non-tumor bearing rats. This hypercatabolic pattern was associated with marked perturbations of the hormonal homeostasis and presence of tumor necrosis factor in the circulation. The daily administration of a goat anti-murine TNF IgG to tumor-bearing rats decreased protein degradation rates in skeletal muscle, heart, and liver as compared with tumor-bearing rats receiving a nonimmune goat IgG. The anti-TNF treatment was also effective in attenuating early perturbations in insulin and corticosterone homeostasis. Although these results suggest that tumor necrosis factor plays a significant role in mediating the changes in protein turnover and hormone levels elicited by tumor growth, the inability of such treatment to prevent a reduction in body weight implies that other mediators or tumor-related events were also involved.